The response rate at chemotherapy in advanced Hodgkin's disease reflected by peripheral lymphocyte count
Krizan, Z.; Korec, S.; Bohunický, L.
Neoplasma 25(6): 737-739
1978
ISSN/ISBN: 0028-2685 PMID: 752119 Document Number: 128979
Forty patients with advanced Hodgkin's disease stage III and IV were treated with combination chemotherapy. Absolute lymphocyte count in the peripheral blood was determined before start to chemotherapy. Higher levels of lymphocytes in the peripheral blood were associated with higher chemotherapy response rates. This difference was statistically significant (P less than 0.05).
Document emailed within 1 workday
Related Documents
Rysenga, E.; Linden, M.D.; Carey, J.L.; Ross, C.W.; Schnitzer, B.; Sawdyk, M.; Maeda, K. 1995: Peripheral T-cell non-Hodgkin's lymphoma following treatment of nodular lymphocyte predominance Hodgkin's disease Archives of Pathology and Laboratory Medicine 119(1): 88-91Pralia, M.M. 1984: T- and B-lymphocyte count in the peripheral blood of bronchial asthma patients during exacerbations and remissions of the disease Sovetskaia Meditsina 2: 21-24
Gray, J.L.; Robinson, W.A. 1973: Combination chemotherapy of advanced Hodgkin's disease Rocky Mountain Medical Journal 70(10): 33-37
Fuller, L.M.; Gamble, J.F. 1973: Updated Hodgkin's disease. C. Advanced disease and special problems. Combined chemotherapy-radiotherapy program JAMA 223(2): 168-169
Bezwoda, W.R.; MacDonald, D.F.; Gear, J.S.; Derman, D.P.; Bothwell, T.H.; Sqi, S.; Hurwitz, S.; Lewis, D. 1978: Combination chemotherapy including bleomycin in the treatment of advanced Hodgkin's disease South African Medical Journal 53(10): 369-373
Brusamolino, E.; Lazzarino, M.; Morra, E.; Inverardi, D.; Merante, S.; Castelli, G.; Canevari, A.; Dornini, G.; Bernasconi, C. 1989: Combination chemotherapy with alternating MOPP-ABVD in advanced Hodgkin's disease Haematologica 74(2): 173-179
Gams, R.A.; Durant, J.R.; Bartolucci, A.A. 1982: Chemotherapy for advanced Hodgkin's disease: conclusions from the Southeastern Cancer Study Group Cancer Treatment Reports 66(4): 899-905
Ahmed, T.; Ciavarella, D.; Feldman, E.; Ascensao, J.; Hussain, F.; Engelking, C.; Gingrich, S.; Mittelman, A.; Coleman, M.; Arlin, Z.A. 1989: High-dose, potentially myeloablative chemotherapy and autologous bone marrow transplantation for patients with advanced Hodgkin's disease Leukemia 3(1): 19-22
Odajima, H.; Yakata, M.; Mitsuma, T. 1985: Significance of the granular lymphocyte (NK cells) count in the peripheral blood Rinsho Byori. Japanese Journal of Clinical Pathology 33(1): 77-81
Ramos Zepeda, R.; Ramos Zepeda, R.; Ramos Damian, M.E.; González Rico, B.M.; González Mendoza, A. 1990: Evaluation of immune response in experimental sporotrichosis using T and B lymphocyte count Medicina Cutanea Ibero-Latino-Americana 18(1): 18-22
Pérez de Oteyza, C.; Menéndez Martínez, M.A.; Muro García, R.; Pérez Aznar, C.; Barberán López, J. 1998: Discriminative value for AIDS case of erythrocyte sedimentation rate, immunoglobulins IgA and IgM, and beta 2-microglobulin in combination with the CD4+ lymphocyte count Anales de Medicina Interna 15(8): 411-414
Horikoshi, N.; Inagaki, J.; Ogawa, M. 1983: Chemotherapy for advanced non-Hodgkin's lymphoma with CVP therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 10(8): 1885-1891
Dighiero, G.; Charron, D.; Vaugier, G.; Leporrier, M.; Debré, P.; d'Athis, P.; Binet, J.L. 1978: Comparative study of the peripheral lymphocyte count in controls and in patients with chronic lymphocytic leukemias 4 hours after injection of hydrocortisone Nouvelle Revue Francaise D'hematologie 20(2): 317-322
Meuthen, I.; Mödder, B. 1981: Advanced non-Hodgkin lymphomas in adults. Cytostatic chemotherapy Die Medizinische Welt 32(41): 1545-1547
Fedder, G.; Somers, R. 1982: Non-Hodgkin lymphoma following radio- and chemotherapy of Hodgkin's disease Nederlands Tijdschrift Voor Geneeskunde 126(38): 1730-1733
Pavlovsky, S.; Maschio, M.; Santarelli, M.T.; Muriel, F.S.; Corrado, C.; Garcia, I.; Schwartz, L.; Montero, C.; Sanahuja, F.L.; Magnasco, O. 1988: Randomized trial of chemotherapy versus chemotherapy plus radiotherapy for stage I-II Hodgkin's disease Journal of the National Cancer Institute 80(18): 1466-1473
Jibrin, Y.B.; Yusuph, H.; Garbati, M.A.; Gashau, W.; Abja, U.M.A. 2006: Should absolute lymphocyte count be used as a surrogate marker for CD4+ count in patients with HIV/AIDS? African Journal of Medicine and Medical Sciences 35(1): 9-13
Hb, U.; Satyanarayana; Ashoka 2016: Correlation of absolute lymphocyte count with CD4 count in HIV patients Journal of the Association of Physicians of India 64(1): 52-53
Gautam, H.; Bhalla, P.; Saini, S.; Dewan, R. 2008: Correlation between baseline CD4 + T-Lymphocyte count and plasma viral load in AIDS patients and their early clinical and immunological response to HAART: a preliminary study Indian Journal of Medical Microbiology 26(3): 256-258
Takagi, T.; Sakai, C.; Oguro, M. 1993: Alternating CHOP-MEVP chemotherapy for advanced-stage, intermediate- and high-grade non-Hodgkin's lymphomas Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(14): 2191-2194